Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Recommendations for antibacterial therapy in adults with COVID-19 – an evidence based guideline
Elske Sieswerda, Mark de Boer, Marc J. M. Bonten, et al.
Clinical Microbiology and Infection (2020) Vol. 27, Iss. 1, pp. 61-66
Open Access | Times Cited: 191

Showing 1-25 of 191 citing articles:

Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre, prospective cohort study
Clark D Russell, Cameron J Fairfield, Thomas M Drake, et al.
The Lancet Microbe (2021) Vol. 2, Iss. 8, pp. e354-e365
Open Access | Times Cited: 291
The role of co-infections and secondary infections in patients with COVID-19
Charles Feldman, Ronald Anderson
Pneumonia (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 275
Antimicrobial resistance (AMR) in COVID-19 patients: a systematic review and meta-analysis (November 2019–June 2021)
Ruwandi Kariyawasam, Danielle Julien, Dana C. Jelinski, et al.
Antimicrobial Resistance and Infection Control (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 156
Antimicrobial Resistance Threats in the emerging COVID-19 pandemic: Where do we stand?
Soumya Ghosh, Charné Bornman, Mai M. Zafer
Journal of Infection and Public Health (2021) Vol. 14, Iss. 5, pp. 555-560
Open Access | Times Cited: 155
Few bacterial co-infections but frequent empiric antibiotic use in the early phase of hospitalized patients with COVID-19: results from a multicentre retrospective cohort study in The Netherlands
Zara Karami, Bram T. Knoop, Anton S. M. Dofferhoff, et al.
Infectious Diseases (2020) Vol. 53, Iss. 2, pp. 102-110
Open Access | Times Cited: 150
Gut microbiome dysbiosis in antibiotic-treated COVID-19 patients is associated with microbial translocation and bacteremia
Lucie Bernard, Mericien Venzon, Jon Klein, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 128
Impact of the COVID-19 pandemic on the surveillance, prevention and control of antimicrobial resistance: a global survey
Sara Tomczyk, Angelina Taylor, Allison C. Brown, et al.
Journal of Antimicrobial Chemotherapy (2021) Vol. 76, Iss. 11, pp. 3045-3058
Open Access | Times Cited: 120
Inappropriate antibiotic use in the COVID-19 era: Factors associated with inappropriate prescribing and secondary complications. Analysis of the registry SEMI-COVID
Jorge Calderón‐Parra, A. Muiño-Míguez, Alejandro David Bendala Estrada, et al.
PLoS ONE (2021) Vol. 16, Iss. 5, pp. e0251340-e0251340
Open Access | Times Cited: 99
Impact of SARS-CoV-2 Epidemic on Antimicrobial Resistance: A Literature Review
Francesco Vladimiro Segala, Davide Fiore Bavaro, Francesco Di Gennaro, et al.
Viruses (2021) Vol. 13, Iss. 11, pp. 2110-2110
Open Access | Times Cited: 95
Antimicrobial Use in COVID-19 Patients in the First Phase of the SARS-CoV-2 Pandemic: A Scoping Review
Wenjuan Cong, Ak Narayan Poudel, Nour Alhusein, et al.
Antibiotics (2021) Vol. 10, Iss. 6, pp. 745-745
Open Access | Times Cited: 69
Predictors and microbiology of respiratory and bloodstream bacterial infection in patients with COVID-19: living rapid review update and meta-regression
Bradley J. Langford, Miranda So, Valerie Leung, et al.
Clinical Microbiology and Infection (2021) Vol. 28, Iss. 4, pp. 491-501
Open Access | Times Cited: 68
Bacterial superinfection in adults with COVID-19 hospitalized in two clinics in Medellín-Colombia, 2020
Juan Carlos Cataño, Jaiberth Antonio Cardona‐Arias, Jessica Paola Porras Mancilla, et al.
PLoS ONE (2021) Vol. 16, Iss. 7, pp. e0254671-e0254671
Open Access | Times Cited: 62
Antimicrobial consumption among hospitalized patients with COVID-19 in Pakistan
Zia Ul Mustafa, Muhammad Salman, Mamoon A. Aldeyab, et al.
SN Comprehensive Clinical Medicine (2021) Vol. 3, Iss. 8, pp. 1691-1695
Open Access | Times Cited: 57
Microbiota and COVID-19: Long-term and complex influencing factors
Jiaqi Gang, Haiyu Wang, Xiangsheng Xue, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 45
Prescribing Patterns of Antibiotics According to the WHO AWaRe Classification during the COVID-19 Pandemic at a Teaching Hospital in Lusaka, Zambia: Implications for Strengthening of Antimicrobial Stewardship Programmes
Steward Mudenda, Eustus Nsofu, Patience Chisha, et al.
Pharmacoepidemiology (2023) Vol. 2, Iss. 1, pp. 42-53
Open Access | Times Cited: 29
Incidence of bloodstream infections due to multidrug-resistant pathogens in ordinary wards and intensive care units before and during the COVID-19 pandemic: a real-life, retrospective observational study
Francesco Vladimiro Segala, Pia Clara Pafundi, Maité Masciocchi, et al.
Infection (2023) Vol. 51, Iss. 4, pp. 1061-1069
Open Access | Times Cited: 23
Antimicrobial Resistance Patterns and Antibiotic Use during Hospital Conversion in the COVID-19 Pandemic
Bernardo Alfonso Martínez-Guerra, María Fernanda González-Lara, Nereyda A. de-León-Cividanes, et al.
Antibiotics (2021) Vol. 10, Iss. 2, pp. 182-182
Open Access | Times Cited: 52
Therapeutic strategies for severe COVID-19: a position paper from the Italian Society of Infectious and Tropical Diseases (SIMIT)
Cristina Mussini, Marco Falcone, Silvia Nozza, et al.
Clinical Microbiology and Infection (2021) Vol. 27, Iss. 3, pp. 389-395
Open Access | Times Cited: 45
COVID-19 and Fatal Sepsis Caused by Hypervirulent Klebsiella pneumoniae, Japan, 2020
Tomohiro Hosoda, Sohei Harada, Koh Okamoto, et al.
Emerging infectious diseases (2021) Vol. 27, Iss. 2, pp. 556-559
Open Access | Times Cited: 43
Increased Use of Antibiotics in the Intensive Care Unit During Coronavirus Disease (COVID-19) Pandemic in a Brazilian Hospital
Alice Ramos Oliveira Silva, Diamantino Salgado, Luís Phillipe Nagem Lopes, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 43
Antibiotic misuse and compliance with infection control measures during COVID‐19 pandemic in community pharmacies in Egypt
Asmaa A. Elsayed, Samar F. Darwish, Moataz B. Zewail, et al.
International Journal of Clinical Practice (2021) Vol. 75, Iss. 6
Open Access | Times Cited: 40
Gut microbiome dysbiosis during COVID-19 is associated with increased risk for bacteremia and microbial translocation.
Mericien Venzon, Lucie Bernard, Jon Klein, et al.
Research Square (Research Square) (2021)
Open Access | Times Cited: 40
Secondary Bacterial Infection Rates Among Patients With COVID-19
İlkay Bahçeci, İlknur Esen Yıldız, Omer F Duran, et al.
Cureus (2022)
Open Access | Times Cited: 33
Transparent polyurethane coating with synergistically enhanced antibacterial mechanism composed of low surface free energy and biocide
Jiujiang Ji, Na Liu, Ye Tian, et al.
Chemical Engineering Journal (2022) Vol. 445, pp. 136716-136716
Closed Access | Times Cited: 32
Host transcriptomics and machine learning for secondary bacterial infections in patients with COVID-19: a prospective, observational cohort study
Meagan Carney, Tiana Maria Pelaia, Tracy Chew, et al.
The Lancet Microbe (2024) Vol. 5, Iss. 3, pp. e272-e281
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top